4.5 Article

Superiority of bivalirudin over heparin anticoagulation therapy for extracorporeal membrane oxygenation? Too early to draw conclusions

Related references

Note: Only part of the references are listed.
Article Engineering, Biomedical

Bivalirudin May Reduce the Need for Red Blood Cell Transfusion in Pediatric Cardiac Patients on Extracorporeal Membrane Oxygenation

Desiree S. Machado et al.

Summary: This study compared heparin and bivalirudin for anticoagulant therapy in children receiving ECMO, finding that the heparin group had higher blood loss and required more PRBC transfusions, while the bivalirudin group had a higher survival rate at ECMO decannulation.

ASAIO JOURNAL (2021)

Article Critical Care Medicine

Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin*

Ryan M. Rivosecchi et al.

Summary: Comparison of patients receiving unfractionated heparin or bivalirudin for anticoagulation on venovenous extracorporeal membrane oxygenation revealed that those receiving bivalirudin experienced a decrease in extracorporeal membrane oxygenation circuit-related thrombotic events and reduced volume of blood products administered.

CRITICAL CARE MEDICINE (2021)

Article Critical Care Medicine

Comparison of Bivalirudin Versus Heparin for Maintenance Systemic Anticoagulation During Adult and Pediatric Extracorporeal Membrane Oxygenation

Troy G. Seelhammer et al.

Summary: The study compared the effects of conventional heparin and bivalirudin anticoagulants in adult and pediatric patients receiving extracorporeal membrane oxygenation support. The adult group using bivalirudin showed reduced hospital mortality, while the pediatric group had decreased transfusion requirements in the first 24 hours. No significant differences were found between the two groups in terms of age, sex, and treatment-related complications.

CRITICAL CARE MEDICINE (2021)

Review Cardiac & Cardiovascular Systems

A Review of Bivalirudin for Pediatric and Adult Mechanical Circulatory Support

Tori Taylor et al.

Summary: As mechanical circulatory support becomes more common, the choice of anticoagulants has become more complex. In addition to traditional heparin, bivalirudin has gained attention as a potential alternative, currently used for specific situations such as heparin-induced thrombocytopenia and mechanical circulatory support.

AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2021)

Article Cardiac & Cardiovascular Systems

Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation

Haya Kaseer et al.

JOURNAL OF CARDIAC SURGERY (2020)

Editorial Material Anesthesiology

Anticoagulation in extracorporeal membrane oxygenation: still a challenge

Pietro Bertini et al.

MINERVA ANESTESIOLOGICA (2020)

Editorial Material Critical Care Medicine

Approach to Adult Extracorporeal Membrane Oxygenation Patient Selection

J. Kyle Bohman et al.

CRITICAL CARE MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy

Shea Macielak et al.

PERFUSION-UK (2019)

Article Surgery

Extracorporeal Membrane Oxygenation in Thoracic Surgery: the Anesthesiologist's Perspective

Stephanie Rehers et al.

ZENTRALBLATT FUR CHIRURGIE (2019)

Article Hematology

Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane Oxygenation

James Thomas et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2018)

Article Cardiac & Cardiovascular Systems

Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement The Randomized BRAVO-3 Trial

George D. Dangas et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)

Article Anesthesiology

Bivalirudin Versus Heparin as an Anticoagulant During Extracorporeal Membrane Oxygenation: A Case-Control Study

Marina Pieri et al.

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2013)

Article Medicine, General & Internal

Bivalirudin Started during Emergency Transport for Primary PCI

Philippe Gabriel Steg et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Pharmacology & Pharmacy

Direct thrombin inhibitors

Catherine J. Lee et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)

Article Hematology

The Coagulation System in Children: Developmental and Pathophysiological Considerations

Vera Ignjatovic et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2011)

Editorial Material Public, Environmental & Occupational Health

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Andreas Stang

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)

Article Medicine, General & Internal

Bivalirudin during primary PCI in acute myocardial infarction

Gregg W. Stone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Hematology

Developmental haemostasis - Impact for clinical haemostasis laboratories

P Monagle et al.

THROMBOSIS AND HAEMOSTASIS (2006)